article thumbnail

Goldman's top trades for this upcoming earnings season

CNBC: Investing

Medical technology analyst David Roman rates GE HealthCare a buy and believes its 2% guidance for 2Q and 3Q growth underestimates a strong U.S. Medical technology analyst David Roman rates GE HealthCare a buy and believes its 2% guidance for 2Q and 3Q growth underestimates a strong U.S.

Trading 119
article thumbnail

Innovations in Personal Protective Equipment with Jason Scharton & Scott Shinn

Focus Investment Banking

Jason Scharton : You know, it it, it Cole, it does come down to because when we look at personal safety at three M, we’re looking at, we’ve got one group who works on that for all industries around the world, whether it be, you know, medical or industrial or, or consumer. I’ll start with Jason.

M&A 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Collision Vision: Supporting Employee Health with Richie Seaberry | Saftey First

Focus Investment Banking

Richie is here to talk about how offering comprehensive health benefits like medical, dental and vision coverage and much more can have a tremendous impact on both your employees well being and your business. Medical, dental, vision. I want to do the most amount that I can for my guys and make sure they’re taken care of.

article thumbnail

‘Uniquely empathetic’: Jim Grien remembers his friend and colleague Bernie Marcus

TM Capital

I watched in awe for nearly 25 years as Bernie envisioned groundbreaking philanthropic responses to social and medical challenges. He is vice chairman and co-head of investment banking at TM Capital, a division of Janney. To me, the common thread running through his philanthropy was Bernie’s heart. What a life! Success.

article thumbnail

The Perils of Customer Concentration in M&A

Focus Investment Banking

A deeper dive into the profile of a PCBA manufacturer, with a 60% customer operating in the medical device market, may have less risk than first appears. Diversify sales across industry verticals (automotive, defense, telecom, medical etc.). Consider diversification by acquisition (product mix, customers, geography etc).

M&A 52
article thumbnail

PCE Welcomes Bradley Scharfenberg as Vice President, M&A

PCE

Brad joins us with over a decade of investment banking experience, having advised on more than 30 middle-market M&A transactions across healthcare, consumer, and industrial sectors.

M&A 52
article thumbnail

Cooley’s 2024 Life Sciences M&A Year in Review: M&A Slims Down in 2024, but Will Appetites Grow in 2025?

Cooley M&A

Pharmaceutical companies also are investing heavily in AI-driven solutions to optimize their drug development processes, particularly by leveraging AI platforms to analyze vast datasets and accelerate discovery. The FTC nevertheless has remained focused on the life sciences/medical device sector in other parts of its enforcement efforts.

M&A 64